A large nationwide study has found important differences in the two main ways children have become seriously ill from the coronavirus, findings that can help doctors and parents better recognize conditions and understand more about children in risk of each.
The study, published Wednesday in the journal JAMA, analyzed 1,116 cases of young people who were treated at 66 hospitals in 31 states. Just over half of the patients had acute COVID-19, the predominantly lung-related disease that affects most adults who get sick from the virus, while 539 patients had the inflammatory syndrome that has flared in some children. weeks after having a typically mild illness. Initial infection.
The researchers found some similarities but also significant differences in symptoms and characteristics of the patients, who ranged from infants to 20 years old and were hospitalized last year between March 15 and October 31.
Sign up for The Morning newsletter from the New York Times
Young people with the syndrome, called Multisystemic Inflammatory Syndrome in Children, or MIS-C, were more likely to be between 6 and 12 years old, while more than 80% of patients with acute COVID-19 were under the age of 6 or over 12 years old.
More than two-thirds of the patients with any of these conditions were black or Hispanic, which experts say likely reflects socioeconomic and other factors that have disproportionately exposed some communities to the virus.
“It is still shocking that the vast majority of patients are not white, and that is true for MIS-C and acute COVID,” said Dr. Jean Ballweg, medical director of pediatric heart transplantation and advanced heart failure at Children’s Hospital & Medical Center in Omaha, Nebraska, which was not involved in the study. “There is a clear racial disparity there.”
For reasons that are unclear, although Hispanic youth appeared equally likely to be at risk for both conditions, black children appeared to be at higher risk of developing the inflammatory syndrome than the acute disease, said Dr. Adrienne Randolph, lead author. of the study. and a pediatric intensive care specialist at Boston Children’s Hospital.
One potential clue mentioned by the authors is that with Kawasaki disease, a rare childhood inflammatory syndrome that bears similarities to some aspects of MIS-C, black children appear to have a higher frequency of heart abnormalities and are less responsive to one of the standard treatments. intravenous immunoglobulin.
The researchers found that young people with inflammatory syndrome were significantly more likely to have no underlying medical conditions than those with acute COVID-19. Still, more than a third of acute COVID patients had no prior medical conditions. “It’s not that previously healthy kids are completely blameless here,” Randolph said.
The study evaluated obesity separately from other underlying health conditions and only in patients 2 years of age or older, and found that a somewhat higher percentage of youth with acute COVID-19 were obese.
Dr. Srinivas Murthy, an associate professor of pediatrics at the University of British Columbia, who was not involved in the study, said he was not convinced that the findings established that healthy children were at increased risk for MIS-C. It could be “primarily a numbers game, with the proportion of infected children and the proportion of healthy children out there, rather than saying that there is something immune about healthy children that puts them at a disproportionately higher risk,” he said.
Overall, he said, the study’s documentation of the differences between the two conditions was helpful, especially since it reflected “a reasonably representative set of hospitals in the US.”
Young people with inflammatory syndrome were more likely to need treatment in intensive care units. His symptoms were much more likely to include gastrointestinal problems, inflammation, and affecting the skin and mucous membranes. They were also much more likely to have heart-related problems, although many of the acute COVID patients did not receive detailed cardiac evaluations, the study noted.
About the same proportion of patients with each condition (more than half) required ventilation, and just under a third of those required mechanical ventilation. About the same number of patients in each group died: 10 with MIS-C and eight with acute COVID-19.
The data does not reflect a recent spike in inflammatory syndrome cases that followed an increase in overall COVID-19 infections across the country during the winter holiday season. Some hospitals have reported that there have been a greater number of seriously ill MIS-C patients in the current wave compared to previous waves.
“I will be fascinated to see the comparison from November 1 onwards with this group, because I think we all feel that the children with MIS-C have been even sicker recently,” said Ballweg.
An optimistic sign from the study was that most of the serious heart problems in young people with inflammatory syndrome improved to a normal condition within 30 days. Still, Randolph said the residual effects are unknown, which is why one of her co-authors, Dr. Jane Newburger, associate chief for academic affairs in the department of cardiology at Boston Children’s Hospital, is leading a nationwide study to follow. to children with inflammatory syndrome for up to five years.
“We can’t say 100% with certainty that everything is going to be normal in the long run,” Randolph said.
This article originally appeared in The New York Times.
© 2021 The New York Times Company